東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Hope or hype : = the obsession with ...

Patrick, Donald L.

FindBook

Google Book

Amazon

博客來

Hope or hype : = the obsession with medical advances and the high cost of false promises /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Hope or hype :/ Richard A. Deyo, Donald L. Patrick.
其他題名:	the obsession with medical advances and the high cost of false promises /
作者:	Deyo, Richard A.
其他作者:	Patrick, Donald L.
出版者:	New York :AMACOM, American Management Association, : c2005.,
面頁冊數:	xvi, 335 p. :ill. ;24 cm.
內容註:	Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
內容註:	Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
標題:	Medical care - Technological innovations - United States -
電子資源:	http://www.loc.gov/catdir/toc/ecip051/2004022295.htmlhttp://www.loc.gov/catdir/toc/ecip051/2004022295.html
ISBN:	0814408451 :

Hope or hype : = the obsession with medical advances and the high cost of false promises /
Deyo, Richard A.

Hope or hype :the obsession with medical advances and the high cost of false promises /Richard A. Deyo, Donald L. Patrick. - New York :AMACOM, American Management Association,c2005. - xvi, 335 p. :ill. ;24 cm.

Includes bibliographical references (p. [291]-326) and index.

Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.

ISBN: 0814408451 :US24.95

LCCN: 2004022295Subjects--Topical Terms:

779686
Medical care
--Technological innovations--United States

LC Class. No.: RA418.5.M4 / D49 2005

Dewey Class. No.: 610/.28

Hope or hype : = the obsession with medical advances and the high cost of false promises /
LDR:04013pam a2200205 a 45 001 712559
005 20070410
008 070313s2005 nyua b 001 0 eng
010 $a 2004022295
020 $a 0814408451 : $c US24.95
035 $a IB95T0645
040 $a DLC $c DLC $d DLC
050 0 0 $a RA418.5.M4 $b D49 2005
082 0 0 $a 610/.28 $2 22
100 $a Deyo, Richard A. $3 779685
245 1 0 $a Hope or hype : $b the obsession with medical advances and the high cost of false promises / $c Richard A. Deyo, Donald L. Patrick.
260 $a New York : $c c2005. $b AMACOM, American Management Association,
300 $a xvi, 335 p. : $b ill. ; $c 24 cm.
504 $a Includes bibliographical references (p. [291]-326) and index.
505 0 $a Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Ineffective. inferior or needlessly costly new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
505 0 $a Can there be too much of a good thing? the hazards of uncritically embracing medical advances -- What's the problem? don't we need lifesaving new treatments? -- Medical innovations and American culture: the call of the sirens -- Why more isn't always better: red herrings, side effects, and superbugs -- Why newer isn't always better: unpleasant surprises, recalls, and learning curves -- Social hazards: what we lose by uncritical use of new treatments -- How things really work: opinion makers and regulators of medical advances -- What will you swallow? how drug companies get you to buy more expensive drugs than you may need -- Making friends, playing monopoly, and dirty tricks: other industry strategies -- Stacking the deck? how to get the "right" answer in clinical research -- "Cancer cured--film at 11:00": the media's role in disseminating medical advances -- Doctors and hospitals: fueling the drive for new and more -- Advocacy groups: Mother Teresa's waiting room -- Holes in the safety net: the FDA and the FTC -- Useless, harmful, or marginal: popular treatments that caused unnecessary disability, dollar costs, or death -- Ineffective or inferior new drugs -- Medical devices that disappoint -- Ineffective or needlessly extensive surgery -- Weight loss technology: shedding pounds from your waistline or your wallet? -- Crossing the threshold: improving the transition from "experimental" to "standard care" -- For doctors: evidence-based medicine -- For insurers and researchers: pay now or pay more later -- For all decision makers: getting value for money -- For government: regulatory approaches to improve the dissemination of medical innovations -- For consumers: shared decision making.
650 $a Medical care $x Technological innovations $z United States $x Cost effectiveness. $3 779686
650 $a Medical care $x Technological innovations $z United States $x Evaluation. $3 779687
650 $a Medical care $z United States $x Evaluation. $3 652530
650 $a Medical care, Cost of $z United States. $3 652531
650 $a Medical innovations $x Economic aspects $z United States. $3 779688
650 $a Medical innovations $z United States $x Evaluation. $3 779689
650 $a Medical technology $z United States $x Cost effectiveness. $3 779690
650 $a Medical technology $z United States $x Evaluation. $3 777516
700 $a Patrick, Donald L. $3 652529
856 4 1 $3 Table of contents $u http://www.loc.gov/catdir/toc/ecip051/2004022295.html $z http://www.loc.gov/catdir/toc/ecip051/2004022295.html